Purpose: We assessed the utility of diŠusion-weighted imaging (DWI) with relative signal intensity (rSI) statistical thresholding for delineating prostate cancer tumors. Materials and Methods: Seventeen patients with prostate cancer underwent DWI before total prostatectomy. We measured standard deviation (SD) of the signal intensity (SI) of the lesser pelvic space at DWI, created rSI maps, displaying signal intensities with SDs of only À＋3, À＋3.5, À＋4, or À＋5, and assessed correlation between the proportion of cancerous area on the 4 diŠerent rSI maps and that on pathological slices.
Introduction
Prostate cancer accounts for approximately 28z of new cancer cases and approximately 11z of cancer deaths in the USA. 1 Accurate delineation of the extent of prostate cancer is important given the emergence of focal therapies. 2, 3 Knowledge of tumor location and extent within the prostate can help direct maximal therapy to the largest focus of tumor and minimize damage to surrounding structures, such as the neurovascular bundles, rectal wall, and neck of the bladder.
Magnetic resonance (MR) imaging plays an important role in the evaluation of prostate cancer. T 2 -weighted imaging (T 2 WI) is widely used for pretreatment work-up for prostate cancer, although its accuracy for detecting and localizing cancer is limited by the similar signal patterns of tumor tissue and benign prostatic hyperplasia, prostatitis, and post-biopsy hemorrhage. 4, 5 Various other techniques, including dynamic contrast-enhanced MR imaging (DCE-MRI), MR imaging spectroscopy, and diŠusion-weighted imaging (DWI), may be used to improve the diagnostic utility of MR imaging.
Particularly, DWI has gained widespread popularity for diŠerentiating prostate cancer from noncancerous tissue. [4] [5] [6] [7] DWI demonstrates areas with impeded diŠusion and reduced apparent diŠusion coe‹cients (ADCs) in cancerous tissue. Advantages of DWI are its relatively short acquisition time and the high contrast resolution between cancer and normal tissue. [4] [5] [6] [7] DWI with ADC mapping has been shown to improve the diagnostic performance of T 2 WI for detecting and localizing pro- 9 Use of high-b-value DWI instead of ADC maps requires application of only one b-value, avoids issues of image misregistration, and may therefore be useful for delineating the extent of prostate cancer. However, the lack of an anatomical reference to normalize the SI at DWI makes measurements of tumor size highly dependent on the window level and width applied. We propose using the lesser pelvic space as a reference to determine the relative signal intensity (rSI) of prostate cancer at DWI and herein introduce and assess the utility of DWI with rSI statistical thresholding for delineating cancerous prostate tumors and use histopathology as the reference standard.
Materials and Methods

Patients
Our local institutional review board approved this retrospective study, and all participants provided written informed consent. Patients were included if they had pathologically proven prostate cancer and had undergone prebiopsy and preoperative MR imaging examination of the prostate between August 2008 and April 2010 and total prostatectomy. We excluded patients with previously treated prostate cancer and contraindications to MR imaging, such as implanted pacemaker and claustrophobia. In our institution, patients with clinically suspected prostate cancer undergo MR imaging of the prostate before biopsy as part of the routine work-up.
We included 17 consecutive patients (mean age, 65.8 years; range, 50 to 74 years),ˆve with tubular adenocarcinoma and 12 with adenocarcinoma. The mean preoperative prostate-speciˆc antigen level of these patients was 11.72 ng/mL (range, 4.02 to 24.75 ng/mL); median Gleason score of maximum cancer lesion was 7 (range, 6 to 9); median clinical stage was T2cN0M0 (range, T2aN0M0 to T2cN0M0); and mean time interval between MR imaging and radical prostatectomy was 68 days (range, 9 to 146 days) ( Table 1) .
MR imaging
All MR imaging examinations were performed using a 1.5-tesla system (ECHELON Vega, Hitachi Medical Corporation, Tokyo, Japan) and an 8-channel phased-array body coil (RAPID TM , Hitachi Medical Corporation, Tokyo, Japan); to avoid possible deformations of the prostate that would complicate planning of focal therapies, no endorectal coil was used. The maximum gradient speciˆca-tions were 30 mT/m for amplitude and 150 mT/ m/s for slew rate. The examination protocol comprised the acquisition of images of the patient's prostate, including seminal vesicles.
Axial fast-spin echo T 2 WI was acquired using parameters: repetition time/echo time (TR/TE), 4604/107 ms; slice thickness/gap, 3/0.6 mm; echo factor, 17; bandwidth, 71.2 kHz;ˆeld of view (FOV), 270×243 mm 2 ; matrix, 384×336; in-plane resolution, 0.71×0.8 mm 2 ; number of signal averages, 2; and scan time, 3 min 9 s.
Axial diŠusion-weighted single-shot spin-echo echo-planar images were acquired using parame- Pathological analysis and matching of pathological specimens to MR imaging data After resection, each prostate was horizontally sectioned into 5-mm slices that corresponded as much as possible to the 3-mm axial slices of MR imaging. 7, 11 As part of the routine pathological examination of prostate cancer, faculty pathologists in our institution outlined in ink the margins of the areas of cancer on the sectioned prostate slices and measured the areas of cancerous and noncancerous tissue on the slice with the largest area of tumor.
A board-certiˆed radiologist (S.Y.) with 6 years' experience in abdominal MR imaging matched the sectioned pathological slices with corresponding T 2 -weighted and DW images without knowledge of the pathological cancerous area. Morphological features of the central zone (CZ), transitional zone (TZ), peripheral zone (PZ), apex and base of the prostate, cysts, calciˆcations, and urethra were used as landmarks to match the datasets, as described previously. 7, 12, 13 Importantly, the MR slice that corresponded to the pathological slice with the maximum area of cancer was used for further analysis, as we will describe.
MR imaging analysis
We placed an arbitrarily shaped region of interest (ROI) in the lesser pelvic space, including the prostate, pelvic and thigh bones, and other normal tissue in the space, on the slice with b-value of 1500 s/mm 2 (Fig. 1a) and measured the standard deviation (SD) of the singal intensity within this ROI. We created 4 types of rSI maps for each patient that displayed only signal intensities with SDs of À＋3, À＋3.5, À＋4, and À＋5 measured in the lesser pelvic space. We also created a fused rSI/T 2 WI (Fig. 1) . Subsequently, the observer manually delineated the margins of the prostate and margins of the detected tumor on the rSI maps with SDs of À＋3, À＋3.5, À＋4, and À＋5. Areas of high signal intensity on these maps with areas of low intensity on T 2 WI were considered to indicate cancerous prostate tissue. For each patient, the observer, who was blinded to patient identity, type of rSI map under evaluation, and histopathological results, compared rSIs in a random fashion between 2 types of parametric maps obtained following a wash-out period of at least one week. Areas of prostate cancer and noncancerous prostate tissue on the 4 diŠerent rSI maps were automatically calculated.
Statistical analysis
We calculated the ratio of cancerous area (z) by dividing the area of cancerous prostate tissue by the entire area of prostate tissue, as determined on sectioned prostate slices and 4 diŠerent rSI maps, and we summarized the ratios as means with ranges. Correlations between the ratios of cancerous area on sectioned prostate slices and on the 4 diŠerent rSI maps were assessed using Pearson's correlation analysis. Pº0.05 was considered statistically signiˆcant. Statistical analyses were executed using Microsoft Excel (Microsoft Corporation, Redmond, WA, USA).
Results
All MR images were of diagnostic quality and without artifact and distortion that would compromise image evaluation. We could detect the area of prostate cancer as lesions of high signal intensity in all 17 cases on rSI maps with SD À＋3 (Fig. 2) , but we could not detect it on rSI maps with SDs of À＋3.5 in 2 cases, À＋4 (5 cases), and À＋5 (8 cases). Table 3 and Fig. 3 show the value, mean, and ranges of ratios of cancerous area, and Table 2 delineates the characteristics of these lesions. The ratios of cancerous area were always highest on rSI maps with SD À＋3, followed by those with SD À＋3.5, À＋4, and À＋5. Correlation coe‹cients (R) between ratios of cancerous area on pathological samples and rSI maps were: 0.7464 (P＝0.0006) for SD À＋3; 0.6469 (P＝0.0050) for SD À＋3.5; Fig. 1 . Fusion between relative signal intensity map (rSI) using a threshold of À＋3 standard deviation (SD) of the signal intensity (SI) of the lesser pelvic space at diŠusion-weighted imaging (DWI) with a b-value of 1500 s/mm 2 (a) and T 2 -weighted imaging (T 2 WI) (b). The rSI/T 2 WI fusion image (c) shows the prostate cancer as a structure with high signal intensity (arrow). Note the region of interest drawn on the DWI with a b-value of 1500 s/mm 2 (a) to determine the SI of the lesser pelvic space. Fig. 2 . Sectioned prostate slice with margins of cancer area outlined in ink (a) and corresponding relative signal intensity (rSI)/T 2 -weighted imaging fusion maps with thresholds of À＋3 standard deviation (SD) (b), À＋3.5 SD (c), À＋ 4 SD (d), and À＋5 SD (e) of the signal intensity of the lesser pelvic space at diŠusion-weighted imaging with a b-value of 1500 s/mm 2 . The rSI map with SD À＋3 shows the largest area of cancer (best match with the tumor area delineated on the pathological specimen), whereas the rSI map with SD À＋5 shows the smallest area of cancer. 0.6459 (P＝0.0051) for SD À＋4; and 0.4540 (P＝ 0.0671) for SD À＋5 (Fig. 4) . In this study, the sensitivity and false negative were: 0.85 and 0.15 for SD À＋3; 0.46 and 0.54 for SD À＋3.5; 0.26 and 0.74 for SD À＋4; and 0.14 and 0.86 for SD À＋5.
Discussion
On rSI maps with SD À＋3, we could detect all 17 prostate cancers, whereas we could not on maps with SDs of À＋3.5, À＋4, and À＋5, and sensitivity was greater than that of the other maps with SD À＋3. Furthermore, correlation between ratios of cancerous area on pathological samples and rSI maps was better when we used a threshold SI of the lesser pelvic space with SD À＋3 than with higher threshold values.
Previous studies have shown the advantage of adding DWI to T 2 WI to detect and localize prostate cancer. 6, 7, 9 Haider's group 6 reported that for the entire prostate, sensitivity for localizing prostate cancer was signiˆcantly higher (Pº0.001) with Lim and colleagues 7 showed greater sensitivity for prostate cancer detection using T 2 -weighted and ADC data (Reader 1, 88z; Reader 2, 81z; Reader 3, 78z) than T 2 WI (Reader 1, 74z; Reader 2, 67z; Reader 3, 67z) for all readers (P＝0.01 for Reader 1; P＝0.02 for Readers 2 and 3). Speciˆcity of T 2 -weighted and ADC data was greater than that of T 2 WI for Reader 1 (88z vs. 79z, P＝0.03) and Reader 2 (89z vs. 77z, Pº0.001). 7 Katahira and associates 9 assessed the eŠect of using diŠerent b-values to detect prostate cancer on native diŠusion-weighted images and found sensitivity and speciˆcity: of 52.2 and 80.7z for T 2 WI alone; 61.2 and 82.6z for the combination of T 2 WI and DWI at a b-value of 1000 s/mm 2 ; and 73.2 and 89.7z for the combination of T 2 WI and DWI at a b-value of 2000 s/mm 2 . The combination of T 2 WI and DWI at a b-value of 2000 s/mm 2 achieved the highest diagnostic performance, followed by the combination of T 2 WI and DWI at a bvalue of 1000 s/mm 2 . 9 The study by Katahira's group 9 is important because it shows that native diŠusion-weighted images themselves can be used to detect and localize prostate cancer. Advantages of this approach over the use of ADC maps is that higher b-values can be applied that may improve contrast between prostate cancer and surrounding noncancerous tissue 8, 9 and that only one b-value need be applied, which shortens acquisition time and eliminates potential misregistration issues between datasets obtained with diŠerent b-values.
The feasibility of semiquantitative analysis of native DWI as well as its outperformance of quantitative ADC analysis in discriminating benign from malignant pulmonary nodules have also been demonstrated. 14 The present study applied these concepts to the delineation of prostate cancer, an increasingly important need given the emergence of focal therapies. 2, 3 It is important to realize that sensitivity and speciˆcityˆgures of diagnostic tests for detecting and localizing prostate cancer cannot be directly translated to the setting of tumor delineation, which requires decisions on a voxel level. 15 The number of investigations of the use of MR imaging for tumor delineation in prostate cancer remains limited.
In a study of 5 patients with prostate cancer who had undergone T 2 WI, DWI (b-values of 500, 1000, and 2000 s/mm 2 ) with ADC mapping (based on bvalues of 500 and 1000 s/mm 2 ), and DCE-MRI, Groenendaal and associates 15 reported tumor coverage of 44 to 89z by MR imaging-based delineation. The limited tumor coverage by the initial MR imaging-based delineations could be partly caused by errors created during registration and by errors in the processing of tissue. Retrospective application of a margin of approximately 5 mm to the MR imaging-based tumor delineations yielded tumor coverage of 85 to 100z in all patients. 15 Important diŠerences between the study of Groenendaal 15 and ours are that they did not normalize the SI of native DWI and they did investigate the utility of more than one MR imaging sequence for tumor delineation. Therefore, we cannot directly compare their study results with ours. We applied signal values of DWI (b-values of 1500 s/mm 2 ) to rSI maps, so rSI maps were displayed regardless of window width and level.
This study had several limitations. First, our sample size was relatively small, and our study design was retrospective. Future prospective studies that include more patients are necessary to validate rSI for Delineating Prostate Cancer Vol. 11 No. 1, 2012 the rSI mapping method with a proposed threshold of À＋3 SD of the signal intensity of the lesser pelvic space. Second, this proposed threshold may be applicable only for the DWI protocol used in this study; particularly, images acquired with diŠerent b-values may have diŠerent optimal thresholds for rSI mapping. Third, we assessed tumors in a 2-dimensional manner on a single slice, but it would be more appropriate to perform a volumetric analysis using a 3-dimensional tissue processing and registration method. 15 Fourth, although the rSI mapping method with a proposed threshold of À＋3 SD showed good correlation with pathological examination, no comparison was made with ADC maps or other MR imaging sequences. ADC maps were not created because the 2 b-values of 0 and 1500 s/mm 2 that we applied would yield an inaccurate ADC as a result of perfusion eŠects 16 and noise. 8 Given the increasing use of multiple MR imaging techniques in prostate cancer, it is important that future studies investigate which sequence or combination of sequences best delineates prostate cancer. 4, 5 This importance is also underlined by the results of a recent study that showed great variation in consistency between ADC (based on b-values of 300, 500, and 1000 s/mm 2 ) and DCE-MRI parameter maps with regard to tumor delineation among 21 patients with prostate cancer. 17 Knowledge of the inconsistency between diŠerent MR imaging sequences must be considered when planning focal therapies for prostate cancer. 17 Finally, it should be realized that the detection of prostate cancer depends on lesion size and Gleason score; particularly, it may be di‹cult to detect lesions smaller than 4 mm in diameter on DWI because of the generally low spatial resolution. 6 In the present study, we could detect the smallest prostate cancer (4×4 mm 2 ) on pathological examination on the rSI map with SD À＋3. However, this method may be limited in detecting and delineating smaller tumors.
In conclusion, DWI-based rSI mapping may be used to delineate the extent of prostate cancer. We found that use of a threshold of À＋3 SD of the SI of the lesser pelvic space provided the best correlation between ratio of cancerous area on the rSI map and on pathological examination.
